UPDATE ON THE PRE-SALE OF DAMBOVITA CENTER PROJECT

Plaza Centers N.V.
05 December 2024
 

December 05, 2024

PLAZA CENTERS N.V.

UPDATE REGARDING THE PRE-SALE AGREEMENT FOR THE SALE OF THE COMPANY'S INDIRECT SHAREHOLDINGS IN THE DAMBOVITA CENTER PROJECT ("CASA RADIO")

 

Plaza Centers N.V. ("Plaza" or the "Company") announced today that further to its previous announcement dated December 4, 2023 regarding the pre-sale agreement (the "Agreement") with AFI Europe N.V ("AFI" and together with the Company, the "Parties") for the sale of its subsidiary (the "SPV") which holds 75% in the Casa Radio Project (the "Project"); that the Parties have signed an addendum to the Agreement (the "Addendum") which pursuant to the Addendum the Parties agreed to extend the Long Stop Date, which is the date on which the parties will execute a share purchase agreement, subject to the satisfaction of conditions precedent (the "SPA"), until December 31, 2025.

There can be no certainty that the SPA will eventually be executed and/or that the Transaction will be consummated as presented above or at all.

 

Ends

For further details, please contact:

 

Plaza

Ron Hadassi, Executive director;                                                     972-526-076-236

 

Notes to Editors

Plaza Centers N.V. (https://plazacenters.com/) is listed on the Main Board of the London Stock Exchange and on the Warsaw Stock Exchange (LSE: "PLAZ", WSE: "PLZ/PLAZACNTR"), and on the Tel Aviv Stock Exchange ("PLAZ").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings